Semaglutide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, is widely used for type 2 diabetes mellitus and has demonstrated hepatoprotective effects. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.